Physician profile
Bridgett C Bailey
NPI 1306908546
$339.52
in general payments reported to CMS, 2019-2025
10 companies · $35.55 in 2025
The $35.55 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.99 · 2021: $17.03 · 2022: $76.41 · 2023: $131 · 2024: $17.23 · 2025: $35.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $184.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $89.77 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.98 | 2022 | |
| Novo Nordisk INC | $36.46 | 2023-2025 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $35.35 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $26.83 | 2019 | |
| Hikma Pharmaceuticals USA | $24.30 | 2019 | |
| Boston Scientific Corporation | $22.51 | 2023 | Watchman Flx |
| Seqirus USA INC | $17.43 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.03 | 2021 | |
| Merck Sharp & Dohme LLC | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridgett Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.